Interactive role of diastolic dysfunction and ventricular remodeling in asymptomatic subjects at increased risk of heart failure.
Adult
Aged
Algorithms
Asymptomatic Diseases
Diastole
Echocardiography, Doppler
Female
Heart Failure
/ diagnostic imaging
Humans
Hypertrophy, Left Ventricular
/ complications
Image Interpretation, Computer-Assisted
Male
Middle Aged
Predictive Value of Tests
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors
Sex Factors
Stroke Volume
Ventricular Dysfunction, Left
/ complications
Ventricular Function, Left
Ventricular Remodeling
Cardiac remodeling
Diastolic dysfunction
Heart failure
Preserved ejection fraction
Prognosis
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
28
11
2018
accepted:
11
02
2019
pubmed:
1
3
2019
medline:
23
7
2019
entrez:
1
3
2019
Statut:
ppublish
Résumé
Diastolic dysfunction (DD) and left ventricular remodeling (LVR) characterize patients at risk for heart failure (HF). To assess the prognostic impact of different diastolic function algorithms and a complex LVR classification (CRC) in asymptomatic subjects with preserved ejection fraction (EF) at risk for HF. We analyzed 1923 asymptomatic patients (male 43%; age 57, 33-76 years) with at least one cardiovascular risk factor and preserved (> 50%) EF. We used three algorithms for LV diastolic function assessment (Paulus et al. in Eur Heart J 28(20):2539-2550, 2007; Nagueh et al. in J Am Soc Echocardiogr 22(2):107-133, 2009, Eur Heart J Cardiovasc Imaging 17(12):1321-1360, 2016), and two algorithms for LVR (classic and CRC). We considered a composite end-point: cardiac death and hospitalization for HF. The highest presence of DD was diagnosed by Nagueh 2009 (211, 11%), while the prevalence according to Nagueh 2016 (63 patients, 3.2%) turned out to be the lowest (p < 0.001 vs the other algorithms). According to CRC, 780 (48.6%) patients had normal or physiologic hypertrophy, 298 (15.5%) concentric remodeling, 85 (4.4%) eccentric remodeling, 294 (15.3%) concentric hypertrophy, 39 (2%) mixed hypertrophy, 80 (4.1%) dilated hypertrophy, 73 (3.7%) eccentric hypertrophy and 294 (15.3%) were unclassifiable. After 39-month follow-up (261 events, 13.6%), Cox-regression (adjusted for age, gender, history of stable ischemic heart disease, classic remodeling classification) identified CRC (p = 0.01) and Nagueh 2016 (p < 0.001) as independent predictors of end-point. The coexistence of an adverse LVR by CRC and DD by Nagueh 2016 was associated with the worst prognosis. A concurrent structural (CRC) and functional (Nagueh Op. Cit) analysis improves prognostic stratification in asymptomatic subjects at risk for HF with preserved EF.
Identifiants
pubmed: 30815808
doi: 10.1007/s10554-019-01560-6
pii: 10.1007/s10554-019-01560-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1231-1240Références
J Am Coll Cardiol. 2003 Feb 19;41(4):687-708
pubmed: 12598084
Circulation. 2003 Aug 26;108(8):977-82
pubmed: 12912813
Am J Cardiol. 1992 Sep 1;70(6):681-8
pubmed: 1387288
J Cardiovasc Med (Hagerstown). 2006 Jul;7(7):457-63
pubmed: 16801805
J Am Coll Cardiol. 2007 Feb 13;49(6):687-94
pubmed: 17291934
Eur Heart J. 2007 Oct;28(20):2539-50
pubmed: 17428822
Circulation. 2008 May 13;117(19):2544-65
pubmed: 18391114
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
J Am Coll Cardiol. 2010 Mar 16;55(11):1057-65
pubmed: 20223363
JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108
pubmed: 21232712
JAMA. 2011 Aug 24;306(8):856-63
pubmed: 21862747
J Am Coll Cardiol. 2011 Oct 18;58(17):1733-40
pubmed: 21996383
Circulation. 2011 Dec 6;124(23):2491-501
pubmed: 22064591
Circ Heart Fail. 2014 Jan;7(1):104-15
pubmed: 24249049
Circ Heart Fail. 2014 Mar 1;7(2):288-99
pubmed: 24365774
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
JACC Heart Fail. 2015 Jun;3(6):445-455
pubmed: 25982111
Eur Heart J Cardiovasc Imaging. 2015 Jun;16(6):577-605
pubmed: 25995329
J Am Coll Cardiol. 2016 Jan 26;67(3):330-7
pubmed: 26796399
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360
pubmed: 27422899
Am J Cardiol. 2017 Jan 1;119(1):71-77
pubmed: 27776801
Circulation. 2017 Jan 17;135(3):224-240
pubmed: 27881564
Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):961-968
pubmed: 28444160
Am J Epidemiol. 2017 Jun 15;185(12):1221-1227
pubmed: 28453616
J Am Soc Hypertens. 2017 Jul;11(7):412-419
pubmed: 28619598
J Am Coll Cardiol. 2017 Jun 27;69(25):3119-3121
pubmed: 28641802
JACC Heart Fail. 2017 Aug;5(8):543-551
pubmed: 28711447
Echocardiography. 2018 Jan;35(1):39-46
pubmed: 29178212
Eur Heart J. 1993 Nov;14 Suppl J:95-101
pubmed: 8281972